OR10H5
gene geneOn this page
Summary
OR10H5 (olfactory receptor family 10 subfamily H member 5, HGNC:15389) is a protein-coding gene on chromosome 19p13.12, encoding Olfactory receptor 10H5 (Q8NGA6). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 284433 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 57 total
- MANE Select transcript:
NM_001004466
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15389 |
| Approved symbol | OR10H5 |
| Name | olfactory receptor family 10 subfamily H member 5 |
| Location | 19p13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000172519 |
| Ensembl biotype | protein_coding |
| Entrez | 284433 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000308940, ENST00000642092
RefSeq mRNA: 1 — MANE Select: NM_001004466
NM_001004466
CCDS: CCDS32940
Canonical transcript exons
ENST00000642092 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003814111 | 15794038 | 15800357 |
| ENSE00003814221 | 15787661 | 15787716 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 56.77.
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 56.77 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 48.63 | gold quality |
| stromal cell of endometrium | CL:0002255 | 47.49 | gold quality |
| muscle tissue | UBERON:0002385 | 47.04 | gold quality |
| ventricular zone | UBERON:0003053 | 46.60 | gold quality |
| cortical plate | UBERON:0005343 | 46.48 | gold quality |
| ganglionic eminence | UBERON:0004023 | 45.41 | gold quality |
| duodenum | UBERON:0002114 | 45.40 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 45.38 | gold quality |
| monocyte | CL:0000576 | 44.82 | gold quality |
| leukocyte | CL:0000738 | 44.42 | gold quality |
| bone marrow | UBERON:0002371 | 43.40 | gold quality |
| liver | UBERON:0002107 | 42.04 | gold quality |
| blood | UBERON:0000178 | 42.03 | gold quality |
| calcaneal tendon | UBERON:0003701 | 41.79 | gold quality |
| islet of Langerhans | UBERON:0000006 | 41.42 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 40.97 | gold quality |
| muscle of leg | UBERON:0001383 | 40.61 | gold quality |
| bone marrow cell | CL:0002092 | 39.96 | gold quality |
| gastrocnemius | UBERON:0001388 | 39.31 | gold quality |
| tonsil | UBERON:0002372 | 39.29 | gold quality |
| right lobe of liver | UBERON:0001114 | 38.99 | gold quality |
| endometrium | UBERON:0001295 | 38.97 | gold quality |
| lymph node | UBERON:0000029 | 38.72 | gold quality |
| pancreas | UBERON:0001264 | 38.48 | silver quality |
| prefrontal cortex | UBERON:0000451 | 38.44 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 38.41 | gold quality |
| primary visual cortex | UBERON:0002436 | 38.18 | gold quality |
| gall bladder | UBERON:0002110 | 38.10 | gold quality |
| vermiform appendix | UBERON:0001154 | 37.68 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-86618 | yes | 41.27 |
| E-ANND-3 | yes | 5.23 |
Regulation
Is transcription factor: no
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or10h1 | ENSMUSG00000093884 |
| mus_musculus | Or10h1b | ENSMUSG00000094891 |
| mus_musculus | Or10h5 | ENSMUSG00000096169 |
| rattus_norvegicus | Olr1092 | ENSRNOG00000073810 |
| rattus_norvegicus | Or10h1 | ENSRNOG00000074063 |
| rattus_norvegicus | Olr1090 | ENSRNOG00000082788 |
| rattus_norvegicus | Olr1093 | ENSRNOG00000090741 |
| rattus_norvegicus | Or10h1d | ENSRNOG00000091234 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 10H5 — Q8NGA6 (reviewed: Q8NGA6)
Alternative names: Olfactory receptor OR19-25, Olfactory receptor OR19-26
All UniProt accessions (2): A0A126GWE9, Q8NGA6
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004466* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGA6-F1 | 88.13 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381753 | Olfactory Signaling Pathway |
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 18 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr19p13, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_OLFACTORY_SIGNALING_PATHWAY, NOTCH3_TARGET_GENES, REACTOME_SENSORY_PERCEPTION
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Sensory Perception | 1 |
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
160 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR10H5 | NPIPB8 | E9PQR5 | 605 |
| OR10H5 | NPIPB9 | F8W1W9 | 577 |
| OR10H5 | CPXCR1 | Q8N123 | 507 |
| OR10H5 | DUSP21 | Q9H596 | 480 |
| OR10H5 | EFCAB13 | Q8IY85 | 464 |
| OR10H5 | AMMECR1 | Q9Y4X0 | 447 |
| OR10H5 | APOL4 | Q9BPW4 | 422 |
| OR10H5 | RABEP2 | Q9H5N1 | 408 |
| OR10H5 | APOBR | Q0VD83 | 400 |
| OR10H5 | ITPRIP | Q8IWB1 | 399 |
| OR10H5 | MRPL52 | Q86TS9 | 397 |
| OR10H5 | KICS2 | Q96MD2 | 394 |
| OR10H5 | GFRA4 | Q9GZZ7 | 370 |
| OR10H5 | SPHKAP | Q2M3C7 | 370 |
| OR10H5 | B4GALT4 | O60513 | 357 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A4D2G3, O60403, O76001, O76002, O76100, O95006, O95047, P23269, P23272, P23274, P30953, P30955, P34984, P58173, P59922, P70526, Q13607, Q15619, Q15622, Q5TZ20, Q60890, Q6IF42, Q7Z3T1, Q8N628, Q8NGA6, Q8NGQ2, Q8NGT7, Q8NGT9, Q8NGX0, Q8NGY5, Q8NGZ4, Q8NGZ5, Q8NGZ6, Q8NHA6, Q8VGD6, Q8VGI1, Q95156, Q96R30, Q96R45, Q96R47
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 7 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
176 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:15794787:ACTGT:A | acceptor_gain | 0.6300 |
| 19:15794795:G:GA | donor_gain | 0.6100 |
| 19:15794856:G:GT | donor_gain | 0.6000 |
| 19:15794712:ATCGT:A | acceptor_gain | 0.5900 |
| 19:15794716:T:TA | acceptor_gain | 0.5900 |
| 19:15794712:ATC:A | acceptor_gain | 0.5800 |
| 19:15794791:T:TA | acceptor_gain | 0.5800 |
| 19:15794705:T:G | acceptor_gain | 0.5600 |
| 19:15794705:T:TA | acceptor_gain | 0.5600 |
| 19:15794714:C:A | acceptor_gain | 0.5600 |
| 19:15794830:TGAAG:T | acceptor_gain | 0.5500 |
| 19:15794717:G:A | acceptor_gain | 0.5400 |
| 19:15794797:T:TA | donor_gain | 0.5300 |
| 19:15794704:AT:A | acceptor_gain | 0.5200 |
| 19:15794712:A:AG | acceptor_gain | 0.5200 |
| 19:15794843:TCCC:T | donor_gain | 0.5200 |
| 19:15794844:CCCC:C | donor_gain | 0.5200 |
| 19:15794792:G:GA | donor_gain | 0.5100 |
| 19:15794414:C:G | donor_gain | 0.5000 |
| 19:15794555:T:TA | acceptor_gain | 0.4900 |
| 19:15794720:C:A | acceptor_gain | 0.4800 |
| 19:15794860:G:GT | donor_gain | 0.4800 |
| 19:15794857:A:T | donor_gain | 0.4600 |
| 19:15794831:G:GT | donor_gain | 0.4400 |
| 19:15794921:CAG:C | acceptor_gain | 0.4400 |
| 19:15794923:G:T | acceptor_gain | 0.4300 |
| 19:15794829:CTGAA:C | acceptor_gain | 0.4200 |
| 19:15794713:T:G | acceptor_gain | 0.4100 |
| 19:15794746:A:C | acceptor_gain | 0.4000 |
| 19:15794796:GTC:G | donor_gain | 0.4000 |
AlphaMissense
2065 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:15794919:T:C | F291L | 0.908 |
| 19:15794921:C:A | F291L | 0.908 |
| 19:15794921:C:G | F291L | 0.908 |
| 19:15794082:T:C | F12L | 0.896 |
| 19:15794084:C:A | F12L | 0.896 |
| 19:15794084:C:G | F12L | 0.896 |
| 19:15794550:T:C | F168L | 0.887 |
| 19:15794552:C:A | F168L | 0.887 |
| 19:15794552:C:G | F168L | 0.887 |
| 19:15794097:T:C | F17L | 0.876 |
| 19:15794099:C:A | F17L | 0.876 |
| 19:15794099:C:G | F17L | 0.876 |
| 19:15794907:A:C | S287R | 0.853 |
| 19:15794909:C:A | S287R | 0.853 |
| 19:15794909:C:G | S287R | 0.853 |
| 19:15794538:T:C | F164L | 0.830 |
| 19:15794540:C:A | F164L | 0.830 |
| 19:15794540:C:G | F164L | 0.830 |
| 19:15794763:T:C | F239L | 0.830 |
| 19:15794765:C:A | F239L | 0.830 |
| 19:15794765:C:G | F239L | 0.830 |
| 19:15794130:T:C | F28L | 0.822 |
| 19:15794132:C:A | F28L | 0.822 |
| 19:15794132:C:G | F28L | 0.822 |
| 19:15794577:T:C | F177L | 0.809 |
| 19:15794579:C:A | F177L | 0.809 |
| 19:15794579:C:G | F177L | 0.809 |
| 19:15794922:A:C | S292R | 0.805 |
| 19:15794924:C:A | S292R | 0.805 |
| 19:15794924:C:G | S292R | 0.805 |
dbSNP variants (sampled 300 via entrez): RS1000127611 (19:15788636 C>T), RS1000242578 (19:15788994 G>A), RS1000420407 (19:15787858 C>T), RS1000572536 (19:15797060 G>T), RS1000625131 (19:15794126 G>C), RS1000641102 (19:15795753 G>A,C), RS1000702891 (19:15789335 C>T), RS1000718919 (19:15796847 C>T), RS1001030062 (19:15790494 G>A), RS1001295006 (19:15791745 T>G), RS1001352764 (19:15793877 TCAAAAA>T), RS1001593028 (19:15788395 C>G,T), RS1001646351 (19:15798520 C>T), RS1001740849 (19:15800369 T>C,G), RS1001773422 (19:15800114 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.